Bingrong Lli

Dr. Bingrong Lli


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
LWLina Wang
Lina Wang
XWXue-Zhi Wang
Xue-Zhi Wang
YLYu-Jia Li
Yu-Jia Li
BLBingrong Lli
Bingrong Lli
MHMeng Huang
Meng Huang
WSWolfgang Schwarz
Wolfgang Schwarz
This review summarizes experimental evidence indicating that subcutaneous mast cells are involved in the trigger mechanism of analgesia induced by acupuncture, a traditional oriental therapy, which has gradually become accepted worldwide. The results are essentially based on work from our laboratories. Skin mast cells are present at a high density in acupuncture points where fine needles are inserted and manipulated during acupuncture intervention. Mast cells are sensitive to mechanical stimulation because they express multiple types of mechanosensitive channels, including TRPV1, TRPV2, TRPV4, receptors and chloride channels. Acupuncture manipulation generates force and torque that indirectly activate the mast cells via the collagen network. Subsequently, various mediators, for example, histamine, serotonin, adenosine triphosphate and adenosine, are released from activated mast cells to the interstitial space; they or their downstream products activate the corresponding receptors situated at local nerve terminals of sensory neurons in peripheral ganglia. The analgesic effects are thought to be generated via the reduced electrical activities of the primary sensory neurons. Alternatively, these neurons project such signals to pain-relevant regions in spinal cord and/or higher centers of the brain.

19 February 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SHSining He
Sining He
LLLele Ling
Lele Ling
YSYaran Sheng
Yaran Sheng
XZXue Zhao
Xue Zhao
LYLong Yuan
Long Yuan
BZBimeng Zhang
Bimeng Zhang
Premature ovarian insufficiency (POI) refers to the decline in ovarian function in women before the age of 40, which can lead to premature ovarian failure and ultimately lead to infertility. In recent years, the incidence of POI has continued to rise, posing a serious threat to women’s reproductive health and mental well-being. Although hormone replacement therapy (HRT) is currently the most widely used Western medical treatment method, its long-term use may carry risks such as thrombosis and breast cancer, and it is not yet an ideal treatment option. Electroacupuncture(EA), as an important intervention method in complementary and alternative medicine (CAM), has been shown to exert multisystem regulatory effects, particularly showing promising prospects in the intervention of POI. This review focuses on the mechanism of action of EA in the treatment of POI. First, the advantages and disadvantages of common animal modeling methods were analyzed. The effects of EA have been studied in terms of improving ovarian function, regulating the hypothalamic–pituitary–ovarian (HPO) axis, balancing the neuroendocrine–immune network, alleviating inflammatory responses, regulating local ovarian blood flow, activating mesenchymal stem cell function, and regulating the intestinal microbiota. Research on the mechanism of EA regulation of POI focused on analyzing the phospholipid 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, Hippo signaling pathway, cell apoptosis, and oxidative stress factors. In addition, this paper summarizes the clinical research progress of different EA treatment regimens in recent years, further verifying their efficacy and safety. Looking ahead, research on EA for POI is expected to achieve breakthroughs with the help of cutting-edge technologies, such as establishing personalized and standardized treatment plans; integrating multidimensional technologies such as genomics, transcriptomics, metabolomics, and tissue clearing; and conducting systematic research on the temporal and spatial dynamic changes in ovarian function. Through the interdisciplinary integration of traditional acupuncture theory and modern life science technology, it is hoped that the underlying mechanisms of EA treatment for POI can be further elucidated, thereby providing a solid theoretical foundation and practical guidance for its clinical application.

21 June 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
LLLele Ling
Lele Ling
SHSining He
Sining He
XZXue Zhao
Xue Zhao
YSYaran Sheng
Yaran Sheng
MHMengying Hong
Mengying Hong
BZBimeng Zhang
Bimeng Zhang
Premature ovarian insufficiency (POI) is a major cause of infertility in young women. In this study, we investigated the therapeutic effects of electroacupuncture (EA) on ovarian function and granulosa cell autophagy in a high‐fat, high‐sugar (HFHS) diet–induced POI mouse model. POI was established by HFHS feeding, and mice received EA stimulation at CV4, ST36, and SP6. Ovarian morphology was evaluated using hematoxylin and eosin (HE), Masson's trichrome, and Sirius Red staining. Estrous cycles were monitored by crystal violet staining, and serum sex hormones and inflammatory cytokines were measured by ELISA. Cholesterol accumulation, apoptosis, and FSHR expression were assessed using filipin staining, TUNEL assays, and immunofluorescence, respectively. Single‐cell RNA sequencing was performed to characterize ovarian cell subpopulations and autophagy‐related transcriptional signatures. Autophagosome formation and the expression of autophagy‐related markers (Beclin1, LC3, and P62), as well as METTL3, were analyzed by transmission electron microscopy (TEM), RT‐qPCR, Western blotting, and immunohistochemistry. m6A modification levels on Beclin1 mRNA were determined using LC–MS, colorimetric assays, and RIP‐qPCR. The results demonstrated that EA significantly improved follicular development, normalized estrous cycles, reduced granulosa cell apoptosis, and decreased inflammatory cytokine levels in POI mice. Single‐cell analysis revealed that granulosa cells exhibited the highest autophagy activity and were strongly associated with senescence‐related pathways. EA markedly reduced autophagosome formation, downregulated Beclin1 and LC3 expression, and upregulated P62, indicating suppression of excessive autophagy. Furthermore, EA decreased METTL3 expression and reduced m6A modification of Beclin1 mRNA, thereby limiting Beclin1 translation. Collectively, these findings suggest that EA ameliorates HFHS‐induced POI by inhibiting METTL3‐mediated m6A methylation of Beclin1 mRNA, suppressing excessive granulosa cell autophagy, and restoring ovarian function, thereby revealing a potential epigenetic mechanism underlying the therapeutic effects of EA in diet‐related ovarian dysfunction.